Balchem (BCPC) SVP awarded shares, options and covers tax with stock

Rhea-AI Filing Summary

Balchem Corporation senior executive Job Leonard van Gunsteren reported multiple equity compensation transactions. On February 11, 2026, he received 430 shares of restricted stock that vest over three years and 1,345 common shares from vesting performance stock units for the 2023–2025 performance period.

To cover tax obligations upon vesting, 756 shares were withheld at $178.68 per share on February 11 and 58 shares were withheld at $177.49 per share on February 12. He was also granted 1,600 stock options at an exercise price of $178.68, vesting 20% in year one, 40% in year two, and 40% in year three. After these transactions he directly owns 10,149 common shares and 1,600 stock options.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider van Gunsteren Job Leonard

Role SVP and GM, Specialty Products

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	58	$177.49	$10K
Grant/Award	Stock Option	1,600	$0.00	--
Grant/Award	Common Stock	430	$0.00	--
Grant/Award	Common Stock	1,345	$0.00	--
Tax Withholding	Common Stock	756	$178.68	$135K

Holdings After Transaction: Common Stock — 10,149 shares (Direct); Stock Option — 1,600 shares (Direct)

Footnotes (1)

1. Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Represents the vesting of performance stock units (includes 22 dividend equivalent shares) for the 2023-2025 performance period. 756 of the 1,345 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting. Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025). Options vest 20% Year 1, 40% Year 2, and 40% Year 3.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

van Gunsteren Job Leonard

(Last) (First) (Middle)

C/O BALCHEM CORPORATION

5 PARAGON DRIVE

(Street)

MONTVALE NJ 07645

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BALCHEM CORP [ BCPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and GM, Specialty Products

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		A		430(1)	A	$0	9,618	D
Common Stock	02/11/2026		A		1,345(2)	A	$0	10,963	D
Common Stock	02/11/2026		F		756(3)	D	$178.68	10,207	D
Common Stock	02/12/2026		F		58(4)	D	$177.49	10,149	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$178.68	02/11/2026		A		1,600		(5)	02/11/2036	Common Stock	1,600	$0	1,600	D

Explanation of Responses:

1. Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.

2. Represents the vesting of performance stock units (includes 22 dividend equivalent shares) for the 2023-2025 performance period.

3. 756 of the 1,345 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting.

4. Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025).

5. Options vest 20% Year 1, 40% Year 2, and 40% Year 3.

	/s/ Travis Larsen, Attorney in Fact for Job Leonard van Gunsteren	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did BCPC executive Job Leonard van Gunsteren report?

He reported equity compensation activity, including grants and vesting. This covered 430 restricted shares, 1,345 shares from vested performance stock units, tax-withholding share dispositions, and a grant of 1,600 stock options, all tied to his role as SVP and GM, Specialty Products.

How many Balchem (BCPC) shares does Job Leonard van Gunsteren own after these transactions?

After the reported transactions, he directly owns 10,149 shares of Balchem common stock. In addition, he holds 1,600 stock options, giving him both current equity ownership and future potential rights to acquire more shares if the options are exercised.

What performance stock units vested for BCPC’s Job Leonard van Gunsteren?

1,345 common shares vested from performance stock units for the 2023–2025 period, including 22 dividend-equivalent shares. These vested shares increased his direct holdings before a portion was withheld to satisfy tax liabilities due upon the vesting event.

Why were some of Job Leonard van Gunsteren’s BCPC shares disposed of in this Form 4?

The dispositions reflect tax-withholding, not open-market sales. Specifically, 756 shares and 58 shares were withheld on separate dates to cover tax liabilities triggered by vesting of performance units and restricted stock, as permitted under the company’s equity compensation arrangements.

What are the terms of the 1,600 Balchem (BCPC) stock options granted to Job Leonard van Gunsteren?

He received 1,600 stock options with an exercise price of $178.68 per share. These options vest over three years: 20% in year one, 40% in year two, and 40% in year three, aligning long-term incentives with company performance.

How do Job Leonard van Gunsteren’s restricted BCPC shares vest over time?

The restricted stock vests across three years under a grant agreement. Vesting occurs 25% on the first anniversary of the grant date, 25% on the second anniversary, and 50% on the third anniversary, with transfer restrictions during the vesting period.